QUOTE AND NEWS
Wall Street Journal  Sep 24  Comment 
Harvard University tapped a longtime insider to head the world's biggest endowment and manage a sprawling investment portfolio worth more than $36 billion.
Benzinga  Sep 3  Comment 
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) +49% - The company announced a collaboration deal with AbbVie Inc. (NYSE: ABBV) to develop and commercialize Infinity’s drug duvelisib. Blyth Inc. (NYSE: BTH) +33% - Visalus founders agreed to...
StreetInsider.com  Sep 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BLYTH%2C+Inc.+%28BTH%29+Higher+on+Deal+with+ViSalus/9801635.html for the full story.
SeekingAlpha  Sep 2  Comment 
By Ellen Brown: You can always count on Americans to do the right thing, after they've tried everything else. -Winston Churchill When an article appears in Foreign Affairs, the mouthpiece of the policy-setting Council on Foreign Relations,...
The Hindu Business Line  Aug 21  Comment 
iBall has launched a Bluetooth headset Rust BTH, in the Gold series. It has an inbuilt microphone and an extra input to make it compatible with devices having a 3.5 mm line-in jack. It has...
SeekingAlpha  Aug 18  Comment 
By Derek Capo: Those that have been following Blyth (NYSE:BTH) know that I have been negative on the company and its management team. Blyth's second-quarter report proves that ViSalus and other segments of the business are far from bottoming. In...
Benzinga  Aug 4  Comment 
QLogic (NASDAQ: QLGC) shares touched a new 52-week low of $8.909 after Barclays downgraded the stock from Overweight to Equal-weight and lowered the price target from $13.00 to $10.00. One Horizon Group (NASDAQ: OHGI) shares fell 5.17% to reach...
SeekingAlpha  Jul 23  Comment 
By Derek Capo: Since 2002, I have followed Blyth Inc. (NYSE:BTH), which was primarily a direct seller of scented candles, due to an acquisition hypothesis that Blyth would complement Berkshire Hathaway's Pampered Chef, a leading MLM (multi-level...
Benzinga  Jul 22  Comment 
Blyth (NYSE: BTH) shares reached a new 52-week low of $6. Blyth's trailing-twelve-month ROE is -1.65%. Adeptus Health (NYSE: ADPT) shares fell 3.65% to touch a new 52-week low of $23.50. Adeptus Health is expected to release its Q2 financial...





You may also be interested in articles related to Blyth (BTH):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki